← Back to headlines
BoFA Lowers PT on Recursion Pharmaceuticals (RXRX), Keeps a Hold Rating
Bank of America has lowered its price target on Recursion Pharmaceuticals (RXRX) while maintaining a Hold rating on the stock.
6 Mar, 17:01 — 6 Mar, 17:01
Sources
Showing 1 of 1 sources
